Ocular Therapeutix News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

10.07.17	Block & Leviton Announces Class Action Lawsuit Against Ocular Therapeutix, Inc. (OCUL) And Encourages Shareholders To Contact The Firm (PR Newswire)
10.07.17	SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Ocular Therapeutix, Inc. (OCUL) & Lead Plaintiff Deadline: September 5, 2017 (PR Newswire)
10.07.17	ITEK Disappoints, ALNY Maps Out ATLAS, ENTL Opens Wallet, D-day Nearing For OCUL (RTTNews)
07.07.17	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ocular Therapeutix, Inc. -- OCUL (PR Newswire)
07.07.17	OCULAR THERAPEUTIX INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Ocular Therapeutix, Inc. To Contact The Firm (PR Newswire)
07.07.17	SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Ocular Therapeutix, Inc. (OCUL) (PR Newswire)
07.07.17	Gainers & Losers Of July 6: VSTM, BGNE, ALRN, TXMD, OCUL... (RTTNews)
29.06.17	Biotech Stocks Facing FDA Decision In July (RTTNews)
05.05.17	Research Reports Initiation on Biotech Stocks -- Trevena, Ocular Therapeutix, INSYS Therapeutics, and Pain Therapeutics (PR Newswire)
28.03.17	Biotech Stocks on Investors' Radar -- Portola Pharma, OvaScience, Ocera Therapeutics, and Ocular Therapeutix (PR Newswire)
17.03.17	Company Spotlight: Ocular Therapeutix (RTTNews)
17.03.17	Gainers & Losers Of Mar.16: MCRB, PLSE, OCUL, PTCT, TROV... (RTTNews)
27.01.17	Research Reports Coverage on Biotech Stocks -- Idera Pharma, Ocular Therapeutix, Radius Health, and Grifols (PR Newswire)
25.01.17	Gainers & Losers Of The Day: GNVC, NVIV, CLRB. AQB, BIOA... (RTTNews)
04.01.17	Ocular Therapeutix Pulls Back Off Early Highs But Remains Positive (RTTNews)
15.12.16	How These Biotech Stocks are Faring? -- Agenus, Kite Pharma, Ocular Therapeutix, and Radius Health (PR Newswire)
15.11.16	FDA Snubs DVAX, Keep An Eye On OCUL, It's All Green For BLUE (RTTNews)
10.11.16	ADAP Surges As FDA Lifts Clinical Hold, OCUL Catches Eyes, RegeneRx On The Rise (RTTNews)
13.10.16	Ocular Therapeutix Signs Strategic Collaboration With Regeneron Pharma (RTTNews)
05.10.16	CATB Data Pushed Back To Q1, SMMT At Peak, TRIB Pounded, OTIC Hits Right Notes (RTTNews)
26.07.16	Good News For GNVC, ACRS On Track, TBRA Tanks, FDA Says No To OCUL (RTTNews)
30.06.16	Biotech Stocks Facing FDA Decision In July (RTTNews)
07.06.16	ADMP Snubbed Again, OCUL, DNAI Skid On Trial Data, AGN Gets FDA Nod. SRPT Abuzz (RTTNews)
28.04.16	New Outlook For NEO, Busy Days Ahead For OASM, OPK's Rayaldee Gets 2nd Chance (RTTNews)
17.02.16	FLXN Flexes Muscles, FDA Approves Broader Use Of Harvoni, Headache For TNXP (RTTNews)
25.11.15	All Well Says ADRO As Stock Slips, LLY Gets FDA Nod, BMRN, OCUL On Watch (RTTNews)
23.10.15	FDA Snubs SPPI, OCUL Feels Pressure, It's Thumbs Up For MACK, But With Rider (RTTNews)
15.10.15	Shareholder Ups Stake In AFMD, Sweet Tidings From DXCM, PFE Snubbed, LLY Beams (RTTNews)
29.09.15	ZSAN Abuzz With Activity, Titan Gets FDA Date, ESPR Down After Hours (RTTNews)
16.06.15	Ocular Therapeutix Begins Enrollment In Phase 3 Trial For DEXTENZA - Quick Facts (RTTNews)
05.06.15	Ocular Therapeutix Reports Pricing Of 4 Mln Shares Public Offering At $22/shr (RTTNews)
07.04.15	QURE Cuts A Deal, CYTX Gets China FDA Nod, OCUL Blacked Out, VTR Opens Wallet (RTTNews)
11.03.15	SUPN Gets Attention, AST For The Long Haul, OCUL To File NDA In Q2, ZGNX Slumps (RTTNews)
10.03.15	Ocular Therapeutix: OTX-DP Phase 3a Trial Meets Primary Efficacy Measures (RTTNews)
22.01.15	SUPN In Legal Bout, NSPR Put On Notice, It's Advantage TEVA, KTWO Gets FDA Nod (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Givaudan	4’040.00	1.71 %	K V
Geberit	547.80	1.59 %	K V
Part Grp Hldg	1’297.00	1.49 %	K V
ABB	51.94	1.29 %	K V
Swiss Life Hldg	691.80	1.26 %	K V
Zurich Insur Gr	548.00	-0.18 %	K V
Kuehne+Nagel Int	210.90	-0.33 %	K V
Swiss Re	128.20	-0.66 %	K V
Sonova Hldg	293.00	-0.85 %	K V
Novartis	87.94	-0.92 %	K V

Nachrichten zu Ocular Therapeutix Inc

Aktien Top/Flop

Meistgelesene Nachrichten